The Distribution and Significance of <em>IDH</em> Mutations in Gliomas
In 2009, the discovery of isocitrate dehydrogenase (IDH) mutations in gliomas is a powerful example of understanding of the relationship between tumor genetics and human diseases. IDHs, catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate with production of NADH/NADPH, is the key...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76304 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Distribution and Significance of <em>IDH</em> Mutations in Gliomas
- The Distribution and Significance of IDH Mutations in Gliomas
- Noncanonical (Non-R132H) IDH-Mutated Gliomas
- Multimodal Oncology Agent for IDH1 Mutation Prediction in Low-Grade Glioma
- Computational Imaging Meets LLMs: Zero-Shot IDH Mutation Prediction in Brain Gliomas
- Prognostic Significance of Immunohistochemical Markers in Glioma Patients
- The Role of Isocitrate Dehydrogenase Mutations in Glioma Brain Tumors